Polymorphisms in tumour necrosis factor α, interleukin-10 and transforming growth factor β1 genes and end-stage liver disease

European Journal of Gastroenterology and Hepatology

Volumn 12, Issue 12, 2000, Pages 1329-1333

  Bathgate, A J ^a   Pravica, V ^a   Perrey, C ^a   Hayes, P C ^a   Hutchinson, I V ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Auto immune hepatitis; Cytokine polymorphisms; Primary biliary cirrhosis; Primary sclerosing cholangitis

Indexed keywords

INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALCOHOL LIVER DISEASE; ALLELE; ARTICLE; AUTOIMMUNE HEPATITIS; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; LIVER CIRRHOSIS; LIVER FAILURE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 0034522924     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200012120-00011     Document Type: Article

References (27)

1. Cytokines and the liver
2. Recent progress in the tumor necrosis factor-α field
3. Interleukin-10: Biology, role in inflammation and autoimmunity
4. Transforming growth factor-β (TGF-β): A key-role in liver fibrogenesis
5. Cytokine profile of viral and auto-immune chronic active hepatitis
6. Tumour necrosis factor (TNF) gene polymorphism influences TNF-α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans
7. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation
8. The -308 tumour necrosis factor-α promoter polymorphism effects transcription
9. Gene polymorphism at position of the tumour necrosis factor α in multiple sclerosis and its influence on the gene regulation of TNFα production
10. Tumour necrosis factor-α promoter polymorphisms in primary biliary cirrhosis
11. Primary biliary cirrhosis shows association with genetic polymorphism of tumour necrosis factor alpha promoter region
12. No evidence for involvement of the interleukin-10 -592 promoter polymorphism in genetic susceptibility to primary biliary cirrhosis
13. Association of tumour necrosis factor polymorphism with primary sclerosing cholangitis
14. Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-βl and tumour necrosis factor-α: A technical report
15. Decreased in vitro production of tumour necrosis factor in primary biliary cirrhosis patients
16. Turnout necrosis factor genomic polymorphisms and outcome of acetaminophen (paracetamol)-induced acute liver failure
17. Cellular expression of tumour necrosis factor-α and interferon-γ in the liver biopsies of children with chronic liver disease
18. Circulating levels of interleukin-6, interleukin-8 and tumour necrosis factor-alpha in children with autoimmune hepatitis
19. Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis
20. Interleukin-10 genotype and susceptibility to inflammatory bowel disease
21. 1 production, fibrotic lung disease and graft fibrosis after lung transplantation
22. Transforming growth factor β1 polymorphism correlates with development of alcoholic cirrhosis
23. Decreased interleukin-10 expression in primary sclerosing cholangitis and primary biliary cirrhosis; a role for IL-10 in the pathogenesis?
24. T-cell responses to tuberculin-purified protein derivative in primary biliary cirrhosis: Evidence for defective T-cell function
25. Genetic associations with immunoregulatory cytokine IL-10 in ulcerative colitis and primary sclerosing cholangitis
26. Transforming growth factor betas and their receptors in human liver cirrhosis
27. Transforming growth factor-β1 in autoimmune hepatitis: Correlation of liver tissue expression and serum levels with disease activity